These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 1696526)
1. CD1+ thymocytes proliferate and give rise to functional cells after stimulation with monoclonal antibodies recognizing CD3, CD2 or CD28 surface molecules. Zocchi MR; Marelli F; Poggi A Cell Immunol; 1990 Sep; 129(2):394-403. PubMed ID: 1696526 [TBL] [Abstract][Full Text] [Related]
2. Antigen-independent pathways of T-cell activation are functional in human immature thymocytes. Poggi A; Zocchi MR Int J Clin Lab Res; 1992; 21(4):304-9. PubMed ID: 1375518 [TBL] [Abstract][Full Text] [Related]
3. "CD3low" human thymocyte populations can readily be triggered via the CD2 and/or CD28 activation pathways whereas the CD3 pathway remains nonfunctional. Pierres A; Cerdan C; Lopez M; Mawas C; Olive D J Immunol; 1990 Feb; 144(4):1202-7. PubMed ID: 1968076 [TBL] [Abstract][Full Text] [Related]
4. Defective signal transduction by the CD2 molecule in immature T-cell receptor/CD3- thymocytes. Turka LA; Fletcher MC; Craighead N; Thompson CB; June CH Proc Natl Acad Sci U S A; 1992 Sep; 89(18):8706-10. PubMed ID: 1382296 [TBL] [Abstract][Full Text] [Related]
5. Activation of CD3/TCR negative human thymocytes via CD28 molecule. Zocchi MR; Poggi A Cell Immunol; 1991 Aug; 136(1):105-12. PubMed ID: 1647880 [TBL] [Abstract][Full Text] [Related]
6. CD28 is an inducible T cell surface antigen that transduces a proliferative signal in CD3+ mature thymocytes. Turka LA; Ledbetter JA; Lee K; June CH; Thompson CB J Immunol; 1990 Mar; 144(5):1646-53. PubMed ID: 2155264 [TBL] [Abstract][Full Text] [Related]
7. A novel activation pathway for mature thymocytes. Costimulation of CD2 (T,p50) and CD28 (T,p44) induces autocrine interleukin 2/interleukin 2 receptor-mediated cell proliferation. Yang SY; Denning SM; Mizuno S; Dupont B; Haynes BF J Exp Med; 1988 Oct; 168(4):1457-68. PubMed ID: 3049912 [TBL] [Abstract][Full Text] [Related]
8. In vitro expansion of CD3/TCR- human thymocyte populations that selectively lack CD3 delta gene expression: a phenotypic and functional analysis. Poggi A; Biassoni R; Pella N; Paolieri F; Bellomo R; Bertolini A; Moretta L; Mingari MC J Exp Med; 1990 Nov; 172(5):1409-18. PubMed ID: 2146363 [TBL] [Abstract][Full Text] [Related]
9. Human T-cell leukemia virus type I-induced proliferation of human immature CD2+CD3- thymocytes. Maguer V; Cassé-Ripoll H; Gazzolo L; Dodon MD J Virol; 1993 Sep; 67(9):5529-37. PubMed ID: 8102412 [TBL] [Abstract][Full Text] [Related]
10. T cell receptor-independent CD2 signal transduction in FcR+ cells. Arulanandam AR; Koyasu S; Reinherz EL J Exp Med; 1991 Apr; 173(4):859-68. PubMed ID: 1706751 [TBL] [Abstract][Full Text] [Related]
11. Differential regulation of Ca2+ mobilization in human thymocytes by coaggregation of surface molecules. Deusch K; Daley JF; Levine H; Languet AJ; Anderson P; Schlossman SF; Blue ML J Immunol; 1990 Apr; 144(8):2851-8. PubMed ID: 1691220 [TBL] [Abstract][Full Text] [Related]
12. CD3Ti+ human thymocyte-derived clones displaying a differential response to activation via CD3Ti and CD2. Testi R; Alcover A; Spagnoli G; Reinherz EL; Acuto O Cell Immunol; 1989 Sep; 122(2):350-64. PubMed ID: 2569934 [TBL] [Abstract][Full Text] [Related]
13. Activation of peripheral CD8+ T lymphocytes via CD28 plus CD2: evidence for IL-2 gene transcription mediated by CD28 activation. Carabasi MH; DiSanto JP; Yang SY; Dupont B Tissue Antigens; 1991 Jan; 37(1):26-32. PubMed ID: 1676547 [TBL] [Abstract][Full Text] [Related]
14. Inhibition by anti-CD2 monoclonal antibodies of anti-CD3-induced T cell-dependent B cell activation. Stohl W; Crow MK Cell Immunol; 1990 Oct; 130(2):257-70. PubMed ID: 1976440 [TBL] [Abstract][Full Text] [Related]
15. Signal transduction via CD4, CD8, and CD28 in mature and immature thymocytes. Implications for thymic selection. Turka LA; Linsley PS; Paine R; Schieven GL; Thompson GB; Ledbetter JA J Immunol; 1991 Mar; 146(5):1428-36. PubMed ID: 1847160 [TBL] [Abstract][Full Text] [Related]
16. Crosslinking CD3 with CD2 using sepharose-immobilized antibodies enhances T lymphocyte proliferation. Anderson P; Blue ML; Morimoto C; Schlossman SF Cell Immunol; 1988 Sep; 115(2):246-56. PubMed ID: 2900689 [TBL] [Abstract][Full Text] [Related]
17. Regulation of T-cell differentiation by CD2 and CD28 accessory molecules. de Jong R; Stokkers P; Lamme E; Kool JM; Borst F; Brouwer M; Miedema F; van Lier RA Immunology; 1991 Oct; 74(2):175-82. PubMed ID: 1684171 [TBL] [Abstract][Full Text] [Related]
18. Activation of human thymocytes by antibodies to the CD3/T-cell receptor complex: triggering of different epitopes results in different signals. Schwinzer R; Sommermeyer H; Schlitt HJ; Schmidt RE; Wonigeit K Cell Immunol; 1991 Sep; 136(2):318-28. PubMed ID: 1714794 [TBL] [Abstract][Full Text] [Related]
19. CD69-mediated pathway of lymphocyte activation: anti-CD69 monoclonal antibodies trigger the cytolytic activity of different lymphoid effector cells with the exception of cytolytic T lymphocytes expressing T cell receptor alpha/beta. Moretta A; Poggi A; Pende D; Tripodi G; Orengo AM; Pella N; Augugliaro R; Bottino C; Ciccone E; Moretta L J Exp Med; 1991 Dec; 174(6):1393-8. PubMed ID: 1720808 [TBL] [Abstract][Full Text] [Related]
20. Human T cell clones with gamma/delta and alpha/beta receptors are differently stimulated by monoclonal antibodies to CD2. Pawelec G; Schaudt K; Rehbein A; Olive D; Bühring HJ Cell Immunol; 1990 Sep; 129(2):385-93. PubMed ID: 1974482 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]